Matthew L. Kaplan - 01 Apr 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Director
Signature
/s/ Matthew Kaplan
Issuer symbol
NVCT
Transactions as of
01 Apr 2022
Net transactions value
$0
Form type
4
Filing time
05 Apr 2022, 16:48:40 UTC
Previous filing
08 Feb 2022
Next filing
16 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCT Stock Options (right to buy) Award $0 +15,000 $0.000000 15,000 01 Apr 2022 Common Stock 15,000 $7.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest according to the following schedule: one-third on each of 4/1/2023, 4/1/2024, and 4/1/2025.